$637 Million is the total value of Samsara BioCapital, LLC's 48 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 75.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $43,089,000 | -3.7% | 3,376,888 | +6.6% | 6.76% | +22.4% |
| ALLK | Buy | ALLAKOS INC | $18,219,000 | +45.9% | 172,089 | +17.7% | 2.86% | +85.5% |
| ALLK | Buy | ALLAKOS INCcall | $17,807,000 | +151.3% | 168,200 | +102.7% | 2.79% | +219.3% |
| New | TANGO THERAPEUTICS INC | $9,051,000 | – | 700,000 | +100.0% | 1.42% | – | |
| ELEV | Buy | ELEVATION ONCOLOGY INC | $7,262,000 | -42.6% | 932,240 | +0.0% | 1.14% | -27.1% |
| New | SURROZEN INC | $2,124,000 | – | 300,000 | +100.0% | 0.33% | – | |
| New | ASTRIA THERAPEUTICS INC | $221,000 | – | 25,000 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.